Biodesix Inc. (BDSX) Misses Q1 EPS by 7c

Biodesix Inc. (NASDAQ: BDSX) reported Q1 EPS of ($0.50), $0.07 worse than the analyst estimate of ($0.43). Revenue for the quarter came in at $6.5 million versus the consensus estimate of $6.45 million.

GUIDANCE:

Biodesix Inc. sees FY2022 revenue of $37.5-39.5 million, versus the consensus of $38.4 million.

For earnings history and earnings-related data on Biodesix Inc. (BDSX) click here.

You May Also Be Interested In

• AEVEX Corp. (AVEX) Reports Q2 EPS of $0.01; offers guidance
• Cerebras Systems Inc. (CBRS) Misses Q2 EPS by $2.80, Misses on Revenue; Offers FY26 Revenue Guidance
• Coherent, Inc. (COHR) Tops Q4 EPS by 12c, Offers Guidance